Summary:
An investigational study is being conducted for the treatment of Generalized Anxiety Disorder (GAD). Participants will receive investigational medication for a duration of 56 days.
Qualified Participants Must:
• Qualified participants must be 18-65 years of age and have been diagnosed with Generalized Anxiety Disorder (GAD).
Qualified Participants May Receive:
Qualified participants will receive study-related medical care and investigational medication at no cost and may be compensated for his/her time and inconvenience related to his/her participation in the study.